Session IV of the 2006 WTC Catalyst Program, Positioning Science in a Commercial Context, will take place on September 15, 2006 from 2:00 to 3:45 p.m. The speaker for this event include Geoffrey Duyk, MD, PhD, TPG Ventures; Pierre Cassigneul, Xdx, Inc.; and Ashley Dombkowski , MPM Capital. The registration price is $27.17 (registration price for all events is $172.00).
Category:
Biotech Industry Events |
Comments Off on 2006 Women’s Technology Cluster Catalyst Program: Session IV–Positioning Science in a Commercial Context
The San Diego Consortium for Systems Biology will be hosting the event RNAi Screening on the Mesa on September 15th from 9 a.m. to 4 p.m. at the Trustee’s Room at the Salk Institute of Biological Studies. The speakers will include Sumit K. Chanda, PhD, Group Leader, Division of Cellular Genomics, The Genomics Institute of the Novartis Research Foundation; Anthony P. Orth, PhD, Group Leader, Gene Core, The Genomics Institute of the Novartis Research Foundation; Pedro Aza-Blanc, PhD, Director, Functional Genomics, The Burnham Institute for Medical Research; Christina Buchanan, PhD, Technical Application Specialist, Ambion; Arumugham Raghunathan, PhD, Sales Development Manager- Advanced Technology Group, Qiagen Inc.; Peter Welch, PhD, Director of Research and Development, Invitrogen Corp.; Edward J. Weinstein, PhD, Principal Biologist, Functional Genomics Department, Sigma-Aldrich Corp.; Troy Moore, PhD, Chief Technical Officer, Open Biosystems; Loren Miraglia, Principal Investigator, Division of Cellular Genomics, The Genomics Institute of the Novartis Research Foundation; and Amy Kiger, PhD, Assistant Professor, Universtiy of California, San Diego.
Session III of the 2006 Women’s Technology Cluster Catalyst Program, Patent Protection/IP Strategy, will be held on September 15, 2006 from 8:30 to 10:15 a.m. at the offices of Pillsbury Winthrop Shaw Pittman LLP at 2475 Hanover Street, Palo Alto, CA 94304. The speakers at this event include Scott Wolf, Prospect Ventures; Karl Handelsman, CMEA Ventures, and Casper De Clercq, US Venture Partners. Registration at this event is $27.17 (registration is $172.00 for the full series).
Category:
Biotech Industry Events |
Comments Off on 2006 Women’s Technology Cluster Catalyst Program: Session III–Patent Protection/IP Strategy
A BIO CEO Presentation Workshop will be held on September 15, 2006 at the offices of Latham & Watkins at 140 Scott Drive Menlo Park, CA 94025. The purpose of the workshop is to enhance the presentation skills of executives who have been chose to present at a BIO investor or venture capital meetings. The workshop is free of charge for one representative from any company selected to present at a BIO investor or venture capital meeting. For all other participants, the cost is $295.
The BIOCOM event Bench to Business and Beyond will take place on September 14th, 2006 from 5:00 to 7:00 p.m. at BIOCOM’s offices at 4510 Executive Drive Plaza 7, San Diego, CA. The event will explore how academia’s innovative technologies are fueling the growth and success of the region’s life sciences companies. The speakers of this event will include: Karen May-Newman, Chair, Mechanical Engineering Department, San Diego State University, and Jackson Streeter, Chairman and Founder, PhotoThera.
BayBio will be holding a BioBQ on Thursday, September 14, 2006 from 5:00-7:30 p.m. at UCSF Mission Bay campus, 600 16th street, 94608. The event will tour the UCSF Mission Bay campus and enable networking with life sciences industry executives, bioentrepreneurs, researchers and faculty, life science practice professionals, financiers and service providers. The advance registration cost is $15.00 and $20.00 on site.
The event Creating Virtual Value:A $527 Million Buyout of Angiosyn by Pfizer will be held on Sept 13th at 7:00 p.m. at Wilson Sonsini Goodrich & Rosati’s offices at 950 Page Mill Road Palo Alto, CA. David Mack, a partner at Alta Partners, will discuss the successful development of Angiosyn and its sale to Pfizer. Also speaking will be Ian Edvalson, who helped broker the transaction with Pfizer
Category:
Biotech Industry Events |
Comments Off on Creating Virtual Value:A $527 Million Buyout of Angiosyn by Pfizer